HAVING JUST COMPLETED SIX months of radiation and chemotherapy for stage 3B colorectal cancer, I'm thankful for an exceptional health care experience and the best possible outcome, which doctors cautiously call "No Evidence of Disease."
Though I'll need anxiety-provoking scans every few months for the foreseeable future, my oncologist reviewed my recent results, congratulated me with all the usual caveats and emphasized: "It's not every day I'm able to share such good news."
His declaration left me relieved but painfully aware of persistent disparities, not only in cancer care but [also] in the way we treat other diseases; namely, addiction.
I'm a white, middle-class, well-insured man who has worked in nonprofit behavioral health services for more than 30 years, so my social determinants of health are admittedly different to others I met in the infusion room.
Cancer care is far from perfect, but the chasm between addiction and the rest of medicine was at once eye-opening and disheartening.
While substance use disorders are more treatable than ever before, over a million Americans have died from overdoses during a 20-year-long opioid crisis, and illegally manufactured fentanyl has driven annual fatalities to record highs.
Alcohol still kills more people than any illicit drug, according to the National Institute on Alcohol Abuse and Alcoholism, and the National Institutes of Health-reported surge in drinking during COVID that's been linked to social isolation, job loss, economic hardship and mental health problems has not yet subsided.
Cocaine and methamphetamine use have risen in the last decade, so much so that some experts are warning that stimulant use may become our nation's next drug epidemic.
This story is from the May 31 - June 07, 2024 (Double Issue) edition of Newsweek US.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 31 - June 07, 2024 (Double Issue) edition of Newsweek US.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
Ray Romano
\"I read about three scripts, and at the end of each there was a little twist, a little turn, [and] it was funny.\"
Has J.K. Rowling Won the Culture War?
After years of backlash over trans issues, the Harry Potter author has received major business backing
Nothin' Lasts Forever
Taylor Swift's Eras Tour' ends its record-breaking run..
SPY IN THE SKY
CHINA FACES ACCUSATIONS of ESPIONAGE and WEAPONIZING OUTER SPACE as it BUILDS a NEW OBSERVATORY in CHILE critics say WILL BE USED for MILITARY PURPOSES
'This Murder Is a Symbol of the Times'
Conservatives and liberals agree on the state of the health care industry following the killing of Brian Thompson
The Defense Industry's Fight With ESG
EUROPEAN DEFENSE COMPANIES, ESPECIALLY smaller businesses, are being blocked from investment they sorely need by sustainability rules, a senior NATO official and several industry figures have said.
Margo Martindale
Jamie Lee [Curtis, producer] called me and she says, \"Jamie Lee Curtis here. I have a project for you. And you're gonna do it.\"
Malala Yousafzai
\"AFGHANISTAN IS THE ONLY COUNTRY IN THE world where girls are banned from access to education and women are limited from work.\"
In the Eyes of the Law
Jude Law is unrecognizable as an FBI agent on the trail of aneo-Naziterrorist group in real-crime drama The Order
Gonzo Intelligence
Instead of keeping a low profile, Moscow's spies are embracing the limelight and even being welcomed home by Vladimir Putin after their cover is blown